Oligonucleotide Synthesis – Overcoming Production Scale Limitations

27 January 2022

The demand for oligonucleotide production facilities has increased significantly in the past year and is likely to continue. Read the article, “Oligonucleotide Synthesis – Overcoming Production Scale Limitations,” by DPS Group’s Joseph Laviano to learn the importance of designing a manufacturing facility that is flexible enough to meet current production needs and has the foresight toward future expansion.

Read the article now